Skip to main content

Articles

Page 213 of 330

  1. Cancer incidence and mortality varies across region, sex and country’s economic status. While most studies focused on global trends, this study aimed to describe and analyse cancer incidence and mortality in A...

    Authors: Chirk Jenn Ng, Chin Hai Teo, Nurdiana Abdullah, Wei Phin Tan and Hui Meng Tan
    Citation: BMC Cancer 2015 15:613
  2. Survivors of young adult malignancies are at risk of accumulated exposures to radiation from repetitive diagnostic imaging. We designed a population-based cohort study to describe patterns of diagnostic imagin...

    Authors: Corinne Daly, David R. Urbach, Thérèse A. Stukel, Paul C. Nathan, Wayne Deitel, Lawrence F. Paszat, Andrew S. Wilton and Nancy N. Baxter
    Citation: BMC Cancer 2015 15:612
  3. Recently, we showed that Sulindac (SU; 320 ppm) reduces precancerous lesions in the colon of Pirc rats, mutated in the Apc gene. Surprisingly, previous data in Apc-mutated mice showed that SU, with reported effic...

    Authors: Angelo Pietro Femia, Paulo Victoria Soares, Cristina Luceri, Maura Lodovici, Augusto Giannini and Giovanna Caderni
    Citation: BMC Cancer 2015 15:611
  4. Trials failed to demonstrate additional value of completion axillary lymph node dissection in case of limited sentinel lymph node metastases in breast cancer patients undergoing breast conserving therapy. It h...

    Authors: L. M. van Roozendaal, J. HW de Wilt, T. van Dalen, J. A. van der Hage, L. JA Strobbe, L. J. Boersma, S. C. Linn, M. BI Lobbes, P. MP Poortmans, V. CG Tjan-Heijnen, K. KBT Van de Vijver, J. de Vries, A. H. Westenberg, A. GH Kessels and M. L. Smidt
    Citation: BMC Cancer 2015 15:610
  5. There is increasing evidence supporting the concept of cancer stem cells (CSCs), which are responsible for the initiation, growth and metastasis of tumors. CSCs are thus considered the target for future cancer...

    Authors: Wenyi Gu, Indira Prasadam, Meihua Yu, Fengxia Zhang, Patrick Ling, Yin Xiao and Chengzhong Yu
    Citation: BMC Cancer 2015 15:609
  6. In invasive malignancies, Dll4/Notch signaling inhibition enhances non-functional vessel proliferation and limits tumor growth by reducing its blood perfusion.

    Authors: Dusan Djokovic, Alexandre Trindade, Joana Gigante, Mario Pinho, Adrian L. Harris and Antonio Duarte
    Citation: BMC Cancer 2015 15:608
  7. Veno-occlusive disease, Graft-versus-Host disease, invasive or localized bacterial, viral and fungal infections are known as adverse events after hematopoietic stem cell transplantation representing the major ...

    Authors: Michaela Döring, Karin Melanie Cabanillas Stanchi, Markus Mezger, Annika Erbacher, Judith Feucht, Matthias Pfeiffer, Peter Lang, Rupert Handgretinger and Ingo Müller
    Citation: BMC Cancer 2015 15:607
  8. Although the risk of developing colorectal cancer (CRC) is 2-4 times higher in case of a positive family history, risk-adapted screening programs for family members related to CRC- patients do not exist in the...

    Authors: Andrea Siebenhofer, Jasper Plath, Maja Taubenroth, Susanne Singer, Marlene Hechtner, Anne Dahlhaus, Sandra Rauck, Sylvia Schulz-Rothe, Insa Koné and Ferdinand M. Gerlach
    Citation: BMC Cancer 2015 15:605
  9. The TMPRSS2-ERG gene fusion occurs in about half of prostate cancer (PCa) cases and results in overexpression of the transcription factor ERG. Overexpression of ERG has many effects on cellular function. Howev...

    Authors: Haydn T. Kissick, Seung T. On, Laura K. Dunn, Martin G. Sanda, John M. Asara, Kathryn L. Pellegrini, Jonathan K. Noel and Mohamed S. Arredouani
    Citation: BMC Cancer 2015 15:604
  10. Tumor employs various means to escape immunosurveillance and inhibit immune attack, and strategies have been developed to counteract the inhibitory signals. However, due to the complex suppressive mechanisms i...

    Authors: Yanhong Wu, Zhenling Deng, Yishu Tang, Shuren Zhang and Yu-Qian Zhang
    Citation: BMC Cancer 2015 15:603
  11. Human papillomavirus-positive oropharyngeal squamous cell carcinoma is increasing in incidence worldwide. Current treatments are associated with high survival rates but often result in significant long-term to...

    Authors: Waheeda Owadally, Chris Hurt, Hayley Timmins, Emma Parsons, Sarah Townsend, Joanne Patterson, Katherine Hutcheson, Ned Powell, Matthew Beasley, Nachi Palaniappan, Max Robinson, Terence M. Jones and Mererid Evans
    Citation: BMC Cancer 2015 15:602
  12. The mean 5–6-month survival after failed standard chemotherapy for metastatic colorectal cancer (mCRC) necessitates more effective treatments for refractory mCRC. For untreated mCRC, S-1 + oral leucovorin (SL)...

    Authors: Kazuhisa Yamaguchi, Hiroya Taniguchi, Azusa Komori, Yukiya Narita, Sohei Nitta, Motoo Nomura, Shigenori Kadowaki, Daisuke Takahari, Takashi Ura, Masashi Andoh, Kei Muro, Keita Mori and Yoshinori Igarashi
    Citation: BMC Cancer 2015 15:601
  13. The gain-of-function mutation of the RET proto-oncogene, which encodes a receptor tyrosine kinase, is strongly associated with the development of several medullary thyroid carcinomas (MTCs). Thus, the RET protein...

    Authors: Vishnu Muthuraj Kumarasamy, Yoon-Joo Shin, John White and Daekyu Sun
    Citation: BMC Cancer 2015 15:599
  14. Nasopharyngeal carcinoma (NPC) is an epithelial malignancy highly prevalent in southern China, and incidence rates among Han Chinese people vary according to geographic region. Recently, three independent geno...

    Authors: Wen-Hui Su, Chi-Cking Chiu and Yin Yao Shugart
    Citation: BMC Cancer 2015 15:598
  15. Authors: Marcelo Niglio de Figueiredo, Bärbel Rudolph, Carma L. Bylund, Tanja Goelz, Pia Heußner, Heribert Sattel, Kurt Fritzsche and Alexander Wuensch
    Citation: BMC Cancer 2015 15:596

    The original article was published in BMC Cancer 2015 15:503

  16. Berberine (BBR), a natural alkaloid compound, is used as a non-prescription drug in China for treating diarrhea and gastroenteritis. Many studies have revealed that BBR possesses anticancer effect. However, th...

    Authors: Juan Wang, Yuanqiu Peng, Yuan Liu, Jun Yang, Ning Ding and Wenfu Tan
    Citation: BMC Cancer 2015 15:595
  17. Increasing evidence suggests a close relationship between systemic inflammation and cancer development and progression. The neutrophil to lymphocyte ratio (NLR) has been shown to be an independent prognostic i...

    Authors: Houda Bahig, Daniel Taussky, Guila Delouya, Amal Nadiri, Ariane Gagnon-Jacques, Paule Bodson-Clermont and Denis Soulieres
    Citation: BMC Cancer 2015 15:594
  18. Risk-reducing salpingo-oophorectomy (RRSO) around the age of 40 is currently recommended to BRCA1/2 mutation carriers. This procedure decreases the elevated ovarian cancer risk by 80–96 % but it initiates prematu...

    Authors: Marline G. Harmsen, Marieke Arts-de Jong, Nicoline Hoogerbrugge, Angela H. E. M. Maas, Judith B. Prins, Johan Bulten, Steven Teerenstra, Eddy M. M. Adang, Jurgen M. J. Piek, Helena C van Doorn, Marc van Beurden, Marian J. E. Mourits, Ronald P. Zweemer, Katja N. Gaarenstroom, Brigitte F. M. Slangen, M. Caroline Vos…
    Citation: BMC Cancer 2015 15:593
  19. Although psycho-oncological interventions have been shown to significantly reduce symptoms of anxiety and depression and enhance quality of life, a substantial number of patients with advanced cancer do not re...

    Authors: Katharina Scheffold, Rebecca Philipp, Dorit Engelmann, Frank Schulz-Kindermann, Christina Rosenberger, Karin Oechsle, Martin Härter, Karl Wegscheider, Florian Lordick, Chris Lo, Sarah Hales, Gary Rodin and Anja Mehnert
    Citation: BMC Cancer 2015 15:592
  20. Breast cancer is the most common type of cancer among women worldwide. In low and middle-income countries (LMICs), appropriate selection of medicines on national essential medicines lists (NEMLs) is a first st...

    Authors: Y. T. Bazargani, A. de Boer, J. H. M. Schellens, H. G. M. Leufkens and Aukje K. Mantel-Teeuwisse
    Citation: BMC Cancer 2015 15:591
  21. YKL-40 is a secreted inflammatory protein that its overexpression has been reported to correlate with poor outcome of various malignant diseases, especially in cancer. However, the function of this protein is ...

    Authors: Malvin Jefri, Yi-Ning Huang, Wen-Chien Huang, Chun-San Tai and Wen-Liang Chen
    Citation: BMC Cancer 2015 15:590
  22. Magnetic resonance imaging (MRI) enables a more sensitive detection of brain metastasis and stereotactic irradiation (SRI) efficiently controls brain metastasis. In limited-stage small cell lung cancer (LS-SCL...

    Authors: Yuichi Ozawa, Minako Omae, Masato Fujii, Takashi Matsui, Masato Kato, Shinya Sagisaka, Kazuhiro Asada, Masato Karayama, Toshihiro Shirai, Kazumasa Yasuda, Yutaro Nakamura, Naoki Inui, Kazunari Yamada, Koshi Yokomura and Takafumi Suda
    Citation: BMC Cancer 2015 15:589
  23. Estrogen Receptor alpha (ERα)-positive breast cancer patients receive endocrine therapy, often in the form of tamoxifen. However, resistance to tamoxifen is frequently observed. A signalling cascade that leads...

    Authors: Cristiane Bentin Toaldo, Xanthippi Alexi, Karin Beelen, Marleen Kok, Michael Hauptmann, Maurice Jansen, Els Berns, Jacques Neefjes, Sabine Linn, Rob Michalides and Wilbert Zwart
    Citation: BMC Cancer 2015 15:588
  24. Medical research studies are becoming increasingly important for optimizing the prevention, diagnosis and treatment of illnesses. Participation in research studies can have many benefits for patients. In rando...

    Authors: Michael P. Lux, Thomas Hildebrandt, Sandra-Maria Knetzger, Michael G. Schrauder, Sebastian M. Jud, Alexander Hein, Claudia Rauh, Peter A. Fasching, Matthias W. Beckmann and Falk C. Thiel
    Citation: BMC Cancer 2015 15:587
  25. Accumulation of mitochondrial DNA (mtDNA) damage could enhance the frequency of mitochondrial mutations and promote a variety of mitochondria-related diseases, including cancer. However, the mechanism(s) invol...

    Authors: Maohua Xie, Paul W. Doetsch and Xingming Deng
    Citation: BMC Cancer 2015 15:586
  26. B-cell precursor acute lymphoblastic leukemia (B-ALL) is amongst the leading causes of childhood cancer-related mortality. Its most common chromosomal aberration is the ETV6-RUNX1 fusion gene, with ~25 % of ETV6-...

    Authors: Louise van der Weyden, George Giotopoulos, Kim Wong, Alistair G. Rust, Carla Daniela Robles-Espinoza, Hikari Osaki, Brian J. Huntly and David J. Adams
    Citation: BMC Cancer 2015 15:585
  27. Ductal carcinoma in situ (DCIS) is a non-obligate precursor lesion of invasive breast cancer in which approximately half the patients will progress to invasive cancer. Gaining a better understanding of DCIS pr...

    Authors: Kingsley O. Osuala, Mansoureh Sameni, Seema Shah, Neha Aggarwal, Michelle L. Simonait, Omar E. Franco, Yan Hong, Simon W. Hayward, Fariba Behbod, Raymond R. Mattingly and Bonnie F. Sloane
    Citation: BMC Cancer 2015 15:584
  28. The aim of this study was to evaluate the survival benefit of radical surgery with additional extensive upper abdominal procedures (EUAS) for the treatment of stage IIIC and IV ovarian cancer with bulky upper ...

    Authors: Yulan Ren, Rong Jiang, Sheng Yin, Chao You, Dongli Liu, Xi Cheng, Jie Tang and Rongyu Zang
    Citation: BMC Cancer 2015 15:583
  29. Esophageal adenocarcinoma has the fastest growing incidence of any solid tumor in the Western world. Prognosis remains poor with overall five-year survival rates under 25 %. Only a limited number of patients b...

    Authors: Shereen El-Mashed, Tracey R. O’Donovan, Elaine W. Kay, Ayat R. Abdallah, Mary-Clare Cathcart, Jacintha O’Sullivan, Anthony O’Grady, John Reynolds, Seamus O’Reilly, Gerald C. O’Sullivan and Sharon L. McKenna
    Citation: BMC Cancer 2015 15:582

    The Correction to this article has been published in BMC Cancer 2019 19:1177

  30. Pancreatic cancer, one of the most dreadful gastrointestinal tract malignancies, with the current chemotherapeutic drugs has posed a major impediment owing to poor prognosis and chemo-resistance thereby sugges...

    Authors: Vikas Yadav, Pallavi Varshney, Sarwat Sultana, Jyoti Yadav and Neeru Saini
    Citation: BMC Cancer 2015 15:581
  31. After primary treatment, many cancer survivors experience psychosocial, physical, and lifestyle problems. To address these issues, we developed a web-based computer tailored intervention, the Kanker Nazorg Wijzer

    Authors: Roy A Willems, Catherine AW Bolman, Ilse Mesters, Iris M Kanera, Audrey AJM Beaulen and Lilian Lechner
    Citation: BMC Cancer 2015 15:580
  32. The benefit of better ballistic and higher efficiency of carbon ions for cancer treatment (hadron-therapy) is asserted since decades, especially for unresectable or resistant tumors like sarcomas. However, had...

    Authors: Dounia Houria Hamdi, Sofia Barbieri, François Chevalier, Jean-Emmanuel Groetz, Florence Legendre, Magali Demoor, Philippe Galera, Jean-Louis Lefaix and Yannick Saintigny
    Citation: BMC Cancer 2015 15:579
  33. The objective of this observational study was to assess the influence of patient, tumor, professional and hospital related characteristics on hospital variation concerning guideline adherence in non-Hodgkin’s ...

    Authors: Jozette J.C. Stienen, Rosella P.M.G. Hermens, Lianne Wennekes, Saskia A.M. van de Schans, Richard W.M. van der Maazen, Helena M. Dekker, Janine Liefers, Johan H.J.M. van Krieken, Nicole M.A. Blijlevens and Petronella B. Ottevanger
    Citation: BMC Cancer 2015 15:578
  34. Tumor associated macrophages (TAMs) are present in high density in solid tumors. TAMs share many characteristics with alternatively activated macrophages, also called M2. They have been shown to favor tumor de...

    Authors: Marie Genin, Francois Clement, Antoine Fattaccioli, Martine Raes and Carine Michiels
    Citation: BMC Cancer 2015 15:577
  35. Magnolin is a natural compound abundantly found in Magnolia flos, which has been traditionally used in oriental medicine to treat headaches, nasal congestion and anti-inflammatory reactions. Our recent results ha...

    Authors: Cheol-Jung Lee, Mee-Hyun Lee, Sun-Mi Yoo, Kyung-Il Choi, Ji-Hong Song, Jeong-Hoon Jang, Sei-Ryang Oh, Hyung-Won Ryu, Hye-Suk Lee, Young-Joon Surh and Yong-Yeon Cho
    Citation: BMC Cancer 2015 15:576
  36. To assess the performance of a predictive model of non-response to neoadjuvant chemotherapy (NAC) in patients with breast cancer based on texture, kinetic, and BI-RADS parameters measured from dynamic MRI.

    Authors: N. Michoux, S. Van den Broeck, L. Lacoste, L. Fellah, C. Galant, M. Berlière and I. Leconte
    Citation: BMC Cancer 2015 15:574
  37. Tumor-associated macrophages (TAMs) are implicated in the growth, invasion and metastasis of various solid tumors. However, the phenotype of TAMs in premalignant lesions of solid tumors has not been clarified....

    Authors: Kazumasa Mori, Shigeki Haraguchi, Miki Hiori, Jun Shimada and Yoshihiro Ohmori
    Citation: BMC Cancer 2015 15:573
  38. Young breast cancer survivors are often dissatisfied with the information provided on fertility and sexuality. Our aim was to discuss possible contributing factors and to propose strategies to increase patient...

    Authors: Ali Ben Charif, Anne-Déborah Bouhnik, Dominique Rey, Magali Provansal, Blandine Courbiere, Bruno Spire and Julien Mancini
    Citation: BMC Cancer 2015 15:572
  39. Extracellular vesicles (EVs) are secreted from many cells, carrying cargoes including proteins and nucleic acids. Research has shown that EVs play a role in a variety of biological processes including immunity...

    Authors: Hillary E. Mulvey, Audrey Chang, Jason Adler, Michael Del Tatto, Kimberly Perez, Peter J. Quesenberry and Devasis Chatterjee
    Citation: BMC Cancer 2015 15:571
  40. Tamoxifen, the most frequently used drug for treating estrogen receptor-positive breast cancer, must be converted into active metabolites to exert its therapeutic efficacy, mainly through CYP2D6 enzymes. The o...

    Authors: Ewa E. Hennig, Magdalena Piatkowska, Jakub Karczmarski, Krzysztof Goryca, Elzbieta Brewczynska, Radoslaw Jazwiec, Anna Kluska, Robert Omiotek, Agnieszka Paziewska, Michal Dadlez and Jerzy Ostrowski
    Citation: BMC Cancer 2015 15:570
  41. Obatoclax is a clinical stage drug candidate that has been proposed to target and inhibit prosurvival members of the Bcl-2 family, and thereby contribute to cancer cell lethality. The insolubility of this comp...

    Authors: Mai Nguyen, Regina Cencic, Franziska Ertel, Cynthia Bernier, Jerry Pelletier, Anne Roulston, John R. Silvius and Gordon C. Shore
    Citation: BMC Cancer 2015 15:568
  42. Treatment of pulmonary recurrence from colorectal cancer involving the main bronchus usually entails palliation using interventional bronchoscopy, because the prognosis is generally very poor. Surgical experie...

    Authors: Andrea Imperatori, Nicola Rotolo, Lorenzo Dominioni, Elisa Nardecchia, Maria Cattoni, Laura Cimetti, Cristina Riva, Fausto Sessa and Daniela Furlan
    Citation: BMC Cancer 2015 15:567
  43. This study included a network meta-analysis of evidence from randomized controlled trials (RCTs) to assess the therapeutic outcome of transurethral resection (TUR) in patients with non-muscle-invasive bladder ...

    Authors: Joo Yong Lee, Kang Su Cho, Dong Hyuk Kang, Hae Do Jung, Jong Kyou Kwon, Cheol Kyu Oh, Won Sik Ham and Young Deuk Choi
    Citation: BMC Cancer 2015 15:566
  44. Kallikreins have clinical value as prognostic markers in a subset of malignancies examined to date, including kallikrein 3 (prostate specific antigen) in prostate cancer. We previously demonstrated that kallik...

    Authors: Kristen L. Drucker, Caterina Gianinni, Paul A. Decker, Eleftherios P. Diamandis and Isobel A. Scarisbrick
    Citation: BMC Cancer 2015 15:565

Featured videos

View featured videos from across the BMC-series journals